Cann Group (CVJ) AI Stock Analysis

Top Page

Cann Group

(Frankfurt:CVJ)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Improved Balance SheetThe latest balance sheet is materially more manageable than the prior year, when equity was negative and leverage was distorted. A debt-to-equity ratio of about 0.59 provides a stronger capital base and may improve the company’s ability to sustain operations and pursue recovery.

Negative Factors

Declining RevenueA sharp revenue decline indicates weakening commercial traction in the company’s medicinal cannabis operations and reduces the scale available to absorb fixed costs. Unless reversed, sustained contraction can limit operating leverage, make profitability harder to achieve, and increase dependence on financing or restructuring actions.

Cann Group (CVJ) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 4.92M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): 0.3
Beta (1Y): 3.39
Revenue Growth: -26.37%
EPS Growth: ―
Country: Germany
Employees: 40
Sector: Healthcare
Sector Strength: 51
Industry: Drug Manufacturers - Specialty & Generic

Cann Group Business Overview & Revenue Model

Company Description

Cann Group Limited, established in Port Melbourne, Australia, in 2014, specializes in the comprehensive lifecycle of medicinal cannabis. This includes genetic development, cultivation, manufacturing, clinical assessment, and the distribution of thera...

Cann Group Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:CVJ against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
AU:VIT	44Neutral	AUD 13.25M	-2.98	-9.80%	―	5.74%	-222.22%
AU:EXL	43Neutral	AUD 2.72M	-0.59	-50.35%	―	-4.87%	-9.78%
AU:IDT	41Neutral	AUD 18.20M	-6.88	-13.81%	―	5.93%	66.32%
AU:LGP	41Neutral	AUD 49.68M	-13.04	-1.67%	―	15.21%	-141.82%
AU:PKP	39Underperform	AUD 21.43M	-5.07	4388.00%	―	-19.73%	50.34%

* Healthcare Sector Average

Performance Comparison

DE:CVJ and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:CVJ	Cann Group Ltd.	0.01	0.00	8.33%
AU:EXL	Elixinol Wellness Ltd	0.01	0.00	25.00%
AU:LGP	Little Green Pharma Ltd.	0.06	-0.07	-53.85%
AU:PKP	Althea Group Holdings Ltd.	0.02	-0.01	-23.81%
AU:IDT	IDT Australia Limited	0.04	-0.02	-26.67%
AU:VIT	Cronos Australia Ltd.	0.02	-0.04	-67.74%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Cann Group AI Stock Analysis